HepaRx is developing a small molecule cancer drug that inhibits heparanase (Hpa) enzymatic activity in order to stop the spread of cancer cells. The company is employing the Hpa crystal structure for drug design and development.
HepaRx Ltd.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://heparx.com
Founded2014
Disease Focus
Development Stage
STOCK CODENon Listed
AddressIlan Ramon Street 2,Ness ZionaIsrael
Ilan Ramon Street 2,
Ness Ziona
Israel
Contact Number
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]